Literature DB >> 27080183

Repurposing strategies for tropical disease drug discovery.

Dana M Klug1, Michael H Gelb2, Michael P Pollastri3.   

Abstract

Neglected tropical diseases (NTDs) and other diseases of the developing world, such as malaria, attract research investments that are disproportionately low compared to their impact on human health worldwide. Therefore, pragmatic methods for launching new drug discovery programs have emerged that repurpose existing chemical matter as new drugs or new starting points for optimization. In this Digest we describe applications of different repurposing approaches for NTDs, and provide a means by which these approaches may be differentiated from each other. These include drug repurposing, target repurposing, target class repurposing, and lead repurposing.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug repositioning; Drug repurposing; Lead repurposing; Neglected tropical disease; Piggy-back drug discovery; Target class repurposing; Target repurposing; Tropical disease

Mesh:

Year:  2016        PMID: 27080183      PMCID: PMC4853260          DOI: 10.1016/j.bmcl.2016.03.103

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  43 in total

Review 1.  Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.

Authors:  Michael H Gelb; Wesley C Van Voorhis; Frederick S Buckner; Kohei Yokoyama; Richard Eastman; Elisabeth P Carpenter; Chrysoula Panethymitaki; Katherine A Brown; Deborah F Smith
Journal:  Mol Biochem Parasitol       Date:  2003-02       Impact factor: 1.759

Review 2.  Protein prenyltransferases.

Authors:  K Yokoyama; G W Goodwin; F Ghomashchi; J Glomset; M H Gelb
Journal:  Biochem Soc Trans       Date:  1992-05       Impact factor: 5.407

Review 3.  Drug repositioning: identifying and developing new uses for existing drugs.

Authors:  Ted T Ashburn; Karl B Thor
Journal:  Nat Rev Drug Discov       Date:  2004-08       Impact factor: 84.694

Review 4.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

5.  Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites.

Authors:  Helen P Price; Malini R Menon; Chrysoula Panethymitaki; David Goulding; Paul G McKean; Deborah F Smith
Journal:  J Biol Chem       Date:  2002-12-17       Impact factor: 5.157

6.  Tamoxifen inhibits acidification in cells independent of the estrogen receptor.

Authors:  N Altan; Y Chen; M Schindler; S M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

7.  Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.

Authors:  Laxman Nallan; Kevin D Bauer; Pravin Bendale; Kasey Rivas; Kohei Yokoyama; Carolyn P Hornéy; Prakash Rao Pendyala; David Floyd; Louis J Lombardo; David K Williams; Andrew Hamilton; Said Sebti; William T Windsor; Patricia C Weber; Frederick S Buckner; Debopam Chakrabarti; Michael H Gelb; Wesley C Van Voorhis
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

8.  An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site.

Authors:  Fernando L Rock; Weimin Mao; Anya Yaremchuk; Mikhail Tukalo; Thibaut Crépin; Huchen Zhou; Yong-Kang Zhang; Vincent Hernandez; Tsutomu Akama; Stephen J Baker; Jacob J Plattner; Lucy Shapiro; Susan A Martinis; Stephen J Benkovic; Stephen Cusack; M R K Alley
Journal:  Science       Date:  2007-06-22       Impact factor: 47.728

9.  Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.

Authors:  Danilo C Miguel; Jenicer K U Yokoyama-Yasunaka; Walter K Andreoli; Renato A Mortara; Silvia R B Uliana
Journal:  J Antimicrob Chemother       Date:  2007-06-21       Impact factor: 5.790

10.  Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.

Authors:  Wesley C Van Voorhis; Kasey L Rivas; Pravin Bendale; Laxman Nallan; Carolyn Hornéy; Lynn K Barrett; Kevin D Bauer; Brian P Smart; Sudha Ankala; Oliver Hucke; Christophe L M J Verlinde; Debopam Chakrabarti; Corey Strickland; Kohei Yokoyama; Frederick S Buckner; Andrew D Hamilton; David K Williams; Louis J Lombardo; David Floyd; Michael H Gelb
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

View more
  27 in total

1.  Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development.

Authors:  Kelly A Bachovchin; Amrita Sharma; Seema Bag; Dana M Klug; Katherine M Schneider; Baljinder Singh; Hitesh B Jalani; Melissa J Buskes; Naimee Mehta; Scott Tanghe; Jeremiah D Momper; Richard J Sciotti; Ana Rodriguez; Kojo Mensa-Wilmot; Michael P Pollastri; Lori Ferrins
Journal:  J Med Chem       Date:  2019-01-10       Impact factor: 7.446

2.  Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.

Authors:  Jennifer L Woodring; Kelly A Bachovchin; Kimberly G Brady; Mitchell F Gallerstein; Jessey Erath; Scott Tanghe; Susan E Leed; Ana Rodriguez; Kojo Mensa-Wilmot; Richard J Sciotti; Michael P Pollastri
Journal:  Eur J Med Chem       Date:  2017-10-06       Impact factor: 6.514

3.  Structure-property studies of an imidazoquinoline chemotype with antitrypanosomal activity.

Authors:  Dana M Klug; Rosario Diaz-Gonzalez; Travis J DeLano; Eftychia M Mavrogiannaki; Melissa J Buskes; Raeann M Dalton; John K Fisher; Katherine M Schneider; Vivian Hilborne; Melanie G Fritsche; Quillon J Simpson; Westley F Tear; William G Devine; Guiomar Pérez-Moreno; Gloria Ceballos-Pérez; Raquel García-Hernández; Cristina Bosch-Navarrete; Luis Miguel Ruiz-Pérez; Francisco Gamarro; Dolores González-Pacanowska; Maria Santos Martinez-Martinez; Pilar Manzano-Chinchon; Miguel Navarro; Michael P Pollastri; Lori Ferrins
Journal:  RSC Med Chem       Date:  2020-07-10

4.  Antitubercular and Antiparasitic 2-Nitroimidazopyrazinones with Improved Potency and Solubility.

Authors:  Chee Wei Ang; Lendl Tan; Melissa L Sykes; Neda AbuGharbiyeh; Anjan Debnath; Janet C Reid; Nicholas P West; Vicky M Avery; Matthew A Cooper; Mark A T Blaskovich
Journal:  J Med Chem       Date:  2020-11-05       Impact factor: 7.446

Review 5.  A bibliometric review of drug repurposing.

Authors:  Nancy C Baker; Sean Ekins; Antony J Williams; Alexander Tropsha
Journal:  Drug Discov Today       Date:  2018-01-09       Impact factor: 7.851

6.  Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation.

Authors:  Jennifer L Woodring; Ranjan Behera; Amrita Sharma; Justin Wiedeman; Gautam Patel; Baljinder Singh; Paul Guyett; Emanuele Amata; Jessey Erath; Norma Roncal; Erica Penn; Susan E Leed; Ana Rodriguez; Richard J Sciotti; Kojo Mensa-Wilmot; Michael P Pollastri
Journal:  ACS Med Chem Lett       Date:  2018-09-04       Impact factor: 4.345

7.  Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis Therapeutics.

Authors:  Dana M Klug; Laura Tschiegg; Rosario Diaz; Domingo Rojas-Barros; Guiomar Perez-Moreno; Gloria Ceballos; Raquel García-Hernández; Maria Santos Martinez-Martinez; Pilar Manzano; Luis Miguel Ruiz; Conor R Caffrey; Francisco Gamarro; Dolores Gonzalez Pacanowska; Lori Ferrins; Miguel Navarro; Michael P Pollastri
Journal:  J Med Chem       Date:  2019-11-20       Impact factor: 7.446

8.  Small Molecule Inhibitors of Metabolic Enzymes Repurposed as a New Class of Anthelmintics.

Authors:  Rahul Tyagi; Amarendar Reddy Maddirala; Mostafa Elfawal; Chelsea Fischer; Christina A Bulman; Bruce A Rosa; Xin Gao; Ryan Chugani; Mingzhou Zhou; Jon Helander; Paul J Brindley; Chih-Chung Tseng; Iain R Greig; Judy Sakanari; Scott A Wildman; Raffi Aroian; James W Janetka; Makedonka Mitreva
Journal:  ACS Infect Dis       Date:  2018-05-14       Impact factor: 5.084

9.  Scaffold and Parasite Hopping: Discovery of New Protozoal Proliferation Inhibitors.

Authors:  Baljinder Singh; Jean A Bernatchez; Laura-Isobel McCall; Claudia M Calvet; Jasmin Ackermann; Julia M Souza; Diane Thomas; Everton M Silva; Kelly A Bachovchin; Dana M Klug; Hitesh B Jalani; Seema Bag; Melissa J Buskes; Susan E Leed; Norma E Roncal; Erica C Penn; Jessey Erath; Ana Rodriguez; Richard J Sciotti; Robert F Campbell; James McKerrow; Jair L Siqueira-Neto; Lori Ferrins; Michael P Pollastri
Journal:  ACS Med Chem Lett       Date:  2020-01-10       Impact factor: 4.345

10.  Lead Optimization of 3,5-Disubstituted-7-Azaindoles for the Treatment of Human African Trypanosomiasis.

Authors:  Dana M Klug; Eftychia M Mavrogiannaki; Katherine C Forbes; Lisseth Silva; Rosario Diaz-Gonzalez; Guiomar Pérez-Moreno; Gloria Ceballos-Pérez; Raquel Garcia-Hernández; Cristina Bosch-Navarrete; Carlos Cordón-Obras; Claudia Gómez-Liñán; Andreu Saura; Jeremiah D Momper; Maria Santos Martinez-Martinez; Pilar Manzano; Ali Syed; Nelly El-Sakkary; Conor R Caffrey; Francisco Gamarro; Luis Miguel Ruiz-Perez; Dolores Gonzalez Pacanowska; Lori Ferrins; Miguel Navarro; Michael P Pollastri
Journal:  J Med Chem       Date:  2021-06-22       Impact factor: 8.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.